Several semiquantitative metabolic parameters, such as SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG), which reflect 18F-FDG metabolic activity as measured by PET/CT, have been shown to be effective in predicting the status of EGFR mutation in patients with NSCLC [11]. This evidence concerns the gene EGFR and neoplasm.